Nexium vs Pantoloc
A side-by-side look at two gastrointestinal medications advertised on TV. Informational only — not medical advice.
| CA Nexium | CA Pantoloc | |
|---|---|---|
| Generic name | esomeprazole | pantoprazole |
| Drug class | Proton Pump Inhibitor (PPI) | Proton Pump Inhibitor (PPI) |
| Treats | Acid reflux, GERD, ulcers | Acid reflux, GERD, ulcers |
| Category | Gastrointestinal | Gastrointestinal |
| Manufacturer | AstraZeneca | Takeda |
| Year approved | 2001 | 1997 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $9M | $2M |
| Common side effects | Headache, Diarrhea, Nausea, Abdominal pain | Headache, Diarrhea, Nausea, Abdominal pain |
Frequently asked questions
Is Nexium or Pantoloc better?
Neither is universally "better." Nexium (esomeprazole) and Pantoloc (pantoprazole) are both used for gastrointestinal, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Nexium and Pantoloc?
Nexium is a Proton Pump Inhibitor (PPI) made by AstraZeneca, while Pantoloc is a Proton Pump Inhibitor (PPI) made by Takeda. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Nexium has the larger estimated TV advertising budget of the two.